×

Error message

The file could not be created.
  1. Home
  2. Victoria Leclercq
  3. Victoria Leclercq

Primary tabs

Search
Limit to
Export 13 results:
Filters: Author is V Leclercq
2025
How to scale up telemedicine for cancer prevention and care? Recommendations for sustainably implementing telemedicine services within EU health systems, Leclercq, V, Saesen Robbe, Schmitt Tugce, Habimana Katharina, Habl Claudia, Gottlob Anita, Van den Bulcke Marc, and Delnord Marie , Journal of Cancer Policy, Jan-06-2025, Volume 44, (2025)
Inequities to the access to and use of telemedicine among cancer patients in Europe: A scoping review, Leclercq, V, Vandervliet Léopold, Schmitt Tugce, Van den Bulcke Marc, and Delnord Marie , (2025)
Telemedicine in cancer care: lessons from COVID-19 and solutions for Europe, Gottlob, Anita, Schmitt Tugce, Sønderskov Frydensberg, Morten, Rosińska Magdalena, Leclercq V, and Habimana Katharina , European Journal of Public Health, Mar-01-2025, (2025)
2024
Prevalence of SARS-CoV-2 antibodies and associated factors in the adult population of Belgium: a general population cohort study between March 2021 and April 2022, Van der Heyden, Johan, Leclercq V, Duysburgh Els, Cornelissen Laura, Desombere Isabelle, Roukaerts Inge, and Gisle Lydia , Arch Public Health, 2024 May 15, Volume 82, Issue 1, (2024)
Prevalence of SARS-CoV-2 antibodies and associated factors in the adult population of Belgium: a general population cohort study between March 2021 and April 2022, Van der Heyden, Johan, Leclercq V, Duysburgh Els, Cornelissen Laura, Desombere Isabelle, Roukaerts Inge, and Gisle Lydia , Archives of Public Health, Jan-12-2024, Volume 82, Issue 1, (2024)
2022
Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study, Leclercq, V, Van den Houte Nayema, Gisle Lydia, Roukaerts Inge, Barbezange Cyril, Desombere I, Duysburgh Els, and Van der Heyden Johan , Viruses, Jan-05-2022, Volume 14, Issue 5, (2022)
Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study., Leclercq, V, Van den Houte Nayema, Gisle Lydia, Roukaerts Inge, Barbezange Cyril, Desombere I, Duysburgh Els, and Van der Heyden Johan , Viruses, 2022 04 28, Volume 14, Issue 5, (2022)
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium : Results of the second data collection (28/09/21-23/02/22), Van den Houte, Nayema, Leclercq V, Gisle Lydia, and Van der Heyden Johan , 21/04/2022, Brussels, Belgium, p.13, (2022)
2021
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: First results of the SalivaHIS study, Leclercq, V, Van den Houte Nayema, Gisle Lydia, and Van der Heyden Johan , 25/11/2021, Brussels, Belgium, p.80, (2021)
Prevalence of metabolic syndrome and its risk factors among Belgian adults, Leclercq, V, Drieskens Sabine, and Van der Heyden Johan , EUPHA, (2021)
Sixième enquête de santé COVID-19 : résultats préliminaires, Berete, Finaba, Braekman Elise, Bruggeman Helena, Charafeddine Rana, Demarest Stefaan, Drieskens Sabine, Gisle Lydia, Hermans Lize, Leclercq V, and Van der Heyden Johan , 13/04/2021, (2021)
Zesde COVID-19-Gezondheidsenquête. Eerste resultaten, Berete, Finaba, Braekman Elise, Bruggeman Helena, Charafeddine Rana, Demarest Stefaan, Drieskens Sabine, Gisle Lydia, Hermans Lize, Leclercq V, and Van der Heyden Johan , 13/04/2021, (2021)
0
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium, March 2021 - April 2022, Leclercq, V, Gisle Lydia, Van den Houte Nayema, and Van der Heyden Johan , (0)

QR code

QR code for this page URL